Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. Gordon B. HunterIndependent Director | -17,71k | 1,09M | Verkauf | 61,61 | 34,96k | -33,63% |
| 2026-05-14 | Mr. Richard A. D’AmoreIndependent Chairman | -43,70k | 2,65M | Verkauf | 60,71 | 112,59k | -27,96% |
| 2026-05-12 | Mr. Gordon B. HunterIndependent Director | -29,53k | 1,75M | Verkauf | 59,41 | 52,68k | -35,92% |
| 2026-05-11 | Mr. Thomas St. DennisIndependent Director | -1,40k | 86,70k | Verkauf | 61,93 | 61,70k | -2,22% |
| 2026-05-07 | Dr. William John MillerCEO & Director | -100,00k | 5,96M | Verkauf | 59,55 | 419,57k | -19,25% |
| 2026-05-08 | Mr. Gordon B. HunterIndependent Director | -7,75k | 455,15k | Verkauf | 58,76 | 82,21k | -8,61% |
| 2026-05-08 | Ms. Mary Jane RaymondIndependent Director | -1.000,00 | 0,00 | Other Disposition | - | 28,97k | -3,34% |
| 2026-03-20 | Dr. William John MillerCEO & Director | 79,10k | 0,00 | Derivative Exercise and Retained Stock | - | 687,57k | 13,00% |
| 2026-03-20 | Dr. William John MillerCEO & Director | -61,05k | 1,89M | Derivative Exercise and Sale | 31,00 | 687,57k | - |
| 2026-03-20 | Mr. John P. KiernanSenior VP & CFO | -15,05k | 466,52k | Derivative Exercise and Sale | 31,00 | 146,30k | - |
| 2026-03-20 | Mr. John P. KiernanSenior VP & CFO | 15,23k | 0,00 | Derivative Exercise and Retained Stock | - | 146,30k | 11,62% |
| 2026-03-20 | Dr. Adrian DevasahayamSVP of Product Line Management | -10,14k | 314,46k | Derivative Exercise and Sale | 31,00 | 132,52k | - |
| 2026-03-20 | Dr. Adrian DevasahayamSVP of Product Line Management | 16,77k | 0,00 | Derivative Exercise and Retained Stock | - | 132,52k | 14,48% |
| 2026-03-20 | Dr. Peter PorshnevSVP of Unified Engineering | -11,40k | 353,31k | Derivative Exercise and Sale | 31,00 | 195,06k | - |
| 2026-03-20 | Dr. Peter PorshnevSVP of Unified Engineering | 15,51k | 0,00 | Derivative Exercise and Retained Stock | - | 195,06k | 8,64% |
| 2026-03-20 | Ms. Susan WilkersonSVP of Global Sales & Services | -7,00k | 216,88k | Derivative Exercise and Sale | 31,00 | 110,70k | - |
| 2026-03-20 | Ms. Susan WilkersonSVP of Global Sales & Services | 19,91k | 0,00 | Derivative Exercise and Retained Stock | - | 110,70k | 21,94% |
| 2026-03-13 | Dr. Adrian DevasahayamSVP of Product Line Management | 5,11k | 0,00 | Derivative Exercise and Retained Stock | - | 115,38k | 4,64% |
| 2026-03-13 | Dr. Adrian DevasahayamSVP of Product Line Management | -3,15k | 98,18k | Derivative Exercise and Sale | 30,95 - 31,46 | 115,38k | - |
| 2026-03-13 | Dr. William John MillerCEO & Director | 25,92k | 0,00 | Derivative Exercise and Retained Stock | - | 608,47k | 4,45% |
| 2026-03-13 | Dr. William John MillerCEO & Director | -20,16k | 627,27k | Derivative Exercise and Sale | 30,95 - 31,46 | 608,47k | - |
| 2026-03-13 | Ms. Susan WilkersonSVP of Global Sales & Services | 6,08k | 0,00 | Derivative Exercise and Retained Stock | - | 90,23k | 7,22% |
| 2026-03-13 | Ms. Susan WilkersonSVP of Global Sales & Services | -2,19k | 68,14k | Derivative Exercise and Sale | 30,95 - 31,46 | 90,23k | - |
| 2026-03-13 | Dr. Peter PorshnevSVP of Unified Engineering | 4,60k | 0,00 | Derivative Exercise and Retained Stock | - | 178,95k | 2,64% |
| 2026-03-13 | Dr. Peter PorshnevSVP of Unified Engineering | -3,67k | 114,17k | Derivative Exercise and Sale | 30,95 - 31,46 | 178,95k | - |
| 2026-03-13 | Mr. John P. KiernanSenior VP & CFO | 5,90k | 0,00 | Derivative Exercise and Retained Stock | - | 131,08k | 4,71% |
| 2026-03-13 | Mr. John P. KiernanSenior VP & CFO | -6,00k | 186,64k | Derivative Exercise and Sale | 30,95 - 31,46 | 131,08k | - |
| 2026-03-03 | Dr. William John MillerCEO & Director | -50,00k | 1,58M | Verkauf | 31,24 - 32,00 | 414,54k | -10,76% |
| 2025-12-10 | Ms. Susan WilkersonSVP of Global Sales & Services | -33,00k | 1,05M | Verkauf | 31,88 | 52,16k | -38,75% |
| 2025-12-05 | Dr. William John MillerCEO & Director | -25,00k | 800,00k | Verkauf | 32,00 | 464,54k | -5,11% |
| 2025-12-02 | Dr. William John MillerCEO & Director | -25,00k | 727,50k | Verkauf | 29,10 | 489,54k | -4,86% |
| 2025-10-02 | Dr. Adrian DevasahayamSVP of Product Line Management | -3,85k | 130,93k | Verkauf | 34,00 | 78,27k | -4,69% |
| 2025-10-01 | Dr. William John MillerCEO & Director | -25,00k | 800,00k | Verkauf | 32,00 | 514,54k | -4,63% |
| 2025-09-23 | Dr. Adrian DevasahayamSVP of Product Line Management | -4,01k | 120,42k | Verkauf | 30,00 | 82,12k | -4,66% |
| 2025-09-15 | Dr. Adrian DevasahayamSVP of Product Line Management | -4,05k | 105,20k | Verkauf | 26,00 | 86,13k | -4,49% |
| 2025-09-09 | Dr. William John MillerCEO & Director | -25,00k | 625,00k | Verkauf | 25,00 | 539,54k | -4,43% |
| 2025-06-05 | Dr. Adrian DevasahayamSVP of Product Line Management | -11,01k | 225,71k | Verkauf | 20,50 | 89,25k | -10,98% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
